Npc209773

Specifications

51-55-8CAS Number

[(1S,5R)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenylpropanoateIUPAC Name

C17H23NO3Chemical Formula

289.4 g/molMolecular Weight

RefChem:1092872; Npc209773; ATROPINE; 51-55-8; dl-Hyoscyamine; Atropen; Atropin; Tropine tropate; dl-Tropyltropate; Atropinol; Eyesules; Isopto-atropine; Troyl tropate; Atropina; Atropin-flexiolen; (+,-)-Tropyl tropate; Atropin [German]; Atropina [Italian]; hyoscyamine; (+/-)-Atropine; (+-)-hyoscyamine; Tropine, tropate (ester); (+-)-atropine; Tropic acid, ester with tropine; (+/-)-Hyoscyamine; CCRIS 3080; Atropine (USP); Tropic acid, 3-alpha-tropanyl ester; L-Hyoscyamine; Atropinum; Atropine sulfate; HSDB 2199; DL-Tropanyl 2-hydroxy-1-phenylpropionate; 3-tropoyloxytropane; 2-Phenylhydracrylic acid 3-alpha-tropanyl ester; DTXSID4020113; AI3-60219; beta-Phenyl-gamma-oxypropionsaure-tropyl-ester [German]; DL-Tropyl tropate; (3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate; 1alphaH,5alphaH-Tropan-3alpha-ol (+-)-tropate (ester); beta-Phenyl-gamma-oxypropionsaeure-tropyl-ester [German]; (3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl tropate; tropan-3alpha-yl 3-hydroxy-2-phenylpropanoate; 8-Methyl-8-azabicyclo[3.2.1]oct-3-yl tropate; MLS000069795; Tropine tropate;DL-Hyoscyamine; 7C0697DR9I; 8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate; [(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenylpropanoate; [(1S,5R)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl] 3-hydroxy-2-phenyl-propanoate; alpha-(Hydroxymethyl)benzeneacetic acid 8-methyl-8-azabicyclo(3.2.1)oct-3-yl ester; Benzeneacetic acid, alpha-(hydroxymethyl)-8-methyl-8-azabicyclo(3,2,1)oct-3-yl ester, endo-(+-)-; NCGC00017333-03; SMR000058248; AB00694549-11; endo-(+/-)-alpha-(Hydroxymethyl)benzeneacetic acid 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester; 16175-85-2; Benzeneacetic acid, alpha-(hydroxymethyl)-, 8-methyl-8-azabicyclo(3.2.1)oct-3-yl ester, endo-(+-)-; DTXCID20113; (-)-Hycosamine; MFCD00022622; (1R,3r,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 3-hydroxy-2-phenylpropanoate; (1R,3S,5S)-8-METHYL-8-AZABICYCLO[3.2.1]OCTAN-3-YL 3-HYDROXY-2-PHENYLPROPANOATE; [(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenyl-propanoate; CAS-51-55-8; Atropen (TN); Protamine & Atropine; Atropine [USP:BAN]; EINECS 200-104-8; Tropine (+/-)-tropate; Pseudoatropine; ropine tropate; UNII-7C0697DR9I; (3-ENDO)-8-METHYL-8-AZABICYCLO(3.2.1)OCT-3-YL TROPATE; (1S,5R)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate; NCGC00159345-02; Atropine (Standard); 1-alpha-H,5-alpha-H-Tropan-3-alpha-ol (+-)-tropate (ester); ATROPINE [MI]; ATROPINE [VANDF]; ATROPINUM [HPUS]; Opera_ID_1088; ATROPINE [MART.]; HA7DL7YA9K; beta-Phenyl-gamma-oxypropionsaure-tropyl-ester; ATROPINE [USP-RS]; ATROPINE [WHO-DD]; bmse000649; beta-Phenyl-gamma-oxypropionsaeure-tropyl-ester; SCHEMBL2812; Atropine, analytical standard; GTPL320; Benzeneacetic acid, alpha-(hydroxymethyl)-, (3-endo)-8-methyl-8-azabicyclo(3.2.1)oct-3-yl ester; MLS001148094; MLS002695888; ATROPINE [GREEN BOOK]; ATNAA COMPONENT ATROPINE; ATROPINE [EP IMPURITY]; ATROPINE [ORANGE BOOK]; CHEMBL254656; CHEMBL475124; CHEMBL517712; cid_174174; MEGxp0_001878; Atropine ((+/-)-Hyoscyamin); ATROPINE [EP MONOGRAPH]; (+/-)-Tropoyltropan-3beta-ol; ATROPINE [USP MONOGRAPH]; ATROPINE, (+/-)-; Ipratropium Bromide Impurity 52; SCHEMBL26698079; ACon1_000046; CHEBI:16684; CHEBI:78734; DUODOTE COMPONENT ATROPINE; HY-B1205R; ATROPINE ((+/-)-); Atropine, >=95.0% (NT); RKUNBYITZUJHSG-PJPHBNEVSA-N; BDBM200229; DTXSID601141720; HMS2089A16; HMS2231G17; HMS3259M13; HY-B1205; MSK10189; Atropine, >=99% (TLC), powder; Tox21_110816; Tox21_111590; Tox21_200487; 1-alpha-H,5-alpha-H-Tropan-3-alpha-ol (+-)-tropate (ester) (8CI); BDBM50403547; EBC-13875; s4713; SBB005985; AKOS015955538; CS-4834; DB00572; FA32433; NC00493; NCGC00017333-02; NCGC00017333-04; NCGC00017333-05; NCGC00017333-06; NCGC00142514-01; NCGC00142514-03; NCGC00258041-01; NCGC00385525-01; AS-56020; Benzeneacetic acid, alpha-(hydroxymethyl)-8-methyl-8-azabicyclo(3.2.1)oct-3-yl ester, endo-(+-)-; ST057178; Atropine, meets USP testing specifications; A7868; C1504; C01479; D00113; Q26272; AB00694549-12; AB00694549_14; Atropine; Homatropine Hydrobromide EP Impurity D; F866144; rac-tropan-3alpha-yl 3-hydroxy-2-phenylpropanoate; BRD-A27290375-001-01-8; BRD-A27290375-065-01-3; BRD-A27290375-330-01-1; Atropine, European Pharmacopoeia (EP) Reference Standard; HOMATROPINE HYDROBROMIDE IMPURITY D [EP IMPURITY]; 1.ALPHA.H,5.ALPHA.H-TROPAN-3.ALPHA.-OL (+/-)-TROPATE (ESTER); (1R,3R,5S)-8-Methyl-8-azabicyclo[3.2.1]oct-3-yl (2RS)-3-hydroxy-2-phenylpropanoate; (3-endo)-8-Methyl-8-azabicyclo[3.2.1]oct-3-yl alpha-(hydroxymethyl)benzeneacetate; (3-exo)-8-Methyl-8-azabicyclo[3.2.1]oct-3-yl alpha-(hydroxymethyl)benzeneacetate; (3-exo)-8-Methyl-8-azabicyclo[3.2.1]oct-3-yl I+/--(hydroxymethyl)benzeneacetate; (S)-(1R,3r,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 3-hydroxy-2-phenylpropanoate; [(1S,5R)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenyl-propanoate; Atropine for peak identification, European Pharmacopoeia (EP) Reference Standard; rac-(3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate; BENZENEACETIC ACID, .ALPHA.-(HYDROXYMETHYL)-(3-ENDO)-8-METHYL-8-AZABICYCLO(3.2.1)OCT-3-YL ESTER; BENZENEACETIC ACID, .ALPHA.-(HYDROXYMETHYL)-8-METHYL-8-AZABICYCLO(3.2.1)OCT-3-YL ESTER, ENDO-(+/-)-; Benzeneacetic acid, alpha-(hydroxymethyl)- (3-endo)-8-methyl-8-azabicyclo(3.2.1)oct-3-yl ester; Benzeneacetic acid, alpha-(hydroxymethyl)-, (3-exo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester; Benzeneacetic acid, alpha-(hydroxymethyl)-, 8-methyl-8-azabicyclo(3.2.1)oct-3-yl ester, endo-(+/-)-Synonyms